Alberto Falorni

Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity.

Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65).

Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.

CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults.

Autoantibodies in autoimmune polyendocrine syndrome type II.

Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity.

CTLA-4-Ig regulates tryptophan catabolism in vivo.

Lack of association of CCR2-64I and CCR5-Delta 32 with type 1 diabetes and latent autoimmune diabetes in adults.

Humoral responses in type 1 diabetes mellitus.

Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency.

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas.

Addison's disease.

Diabetes incidence in 0- to 14-year age-group in Italy: a 10-year prospective study.

Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.

Selective theca cell dysfunction in autoimmune oophoritis results in multifollicular development, decreased estradiol, and elevated inhibin B levels.

Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease.

Diabetes-related antibodies in adult diabetic patients.

MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.

Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism?

Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)--preliminary data.

MICA A8: a new allele within MHC class I chain-related A transmembrane region with eight GCT repeats.

Mapping of human autoantibody epitopes on aromatic L-amino acid decarboxylase.

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.

High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency.

Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.

Pharmacological causes of hyperprolactinemia.

Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.

Can NK cells be a therapeutic target in human type 1 diabetes?

Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco.

Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.

Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies.

Recombinant human GAD65 accumulates to high levels in transgenic tobacco plants when expressed as an enzymatically inactive mutant.

Association of genetic polymorphisms and autoimmune Addison's disease.

Autoantibody responses in autoimmune ovarian insufficiency and in Addison's disease are IgG1 dominated and suggest a predominant, but not exclusive, Th1 type of response.

Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up.

Primary ovarian insufficiency: autoimmune causes.

Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study.

Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?

Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren.

Non-food/feed seeds as biofactories for the high-yield production of recombinant pharmaceuticals.

Measuring adrenal autoantibody response: interlaboratory concordance in the first international serum exchange for the determination of 21-hydroxylase autoantibodies.

Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL.

Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency.

BClI polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease.

A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred.

GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).

Therapy of adrenal insufficiency: an update.

Comparative analysis of different biofactories for the production of a major diabetes autoantigen.

Diagnosis and classification of autoimmune hypophysitis.

Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.

Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.

Anti-mullerian hormone concentration during the third trimester of pregnancy and puerperium: a longitudinal case-control study in normal and diabetic pregnancy.

Autoantibody response against NALP5/MATER in primary ovarian insufficiency and in autoimmune Addison's disease.